165million is only the unlisted Options from prior performance Shares. There is also the 354 million listed IMUOB and IMUOC as well. But considering this used to be approx 750million across these 3 areas a few months back, a huge number have now already been converted giving a sizeable cash buffer for the Company to go out and continue to find amazing opportunities like the recent 'OnCARlytics' licensing and continue finding these clinical trials.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)